Pseudomonas Aeruginosa Pneumonia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-03-09
Clinical Trial Update: Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa Pneumonia [Phase 2]
Phase 2 clinical trial of adjunctive therapy with AR-105 (Aerucin) for Pseudomonas aeruginosa pneumonia has completed and results were poste…